A PHP Error was encountered

Severity: Warning

Message: fopen(/var/www/meetingsint/application/ci_session/ci_sessionabcc7869d7e6a1dac149dc083cb8be6407bd53b5fa50bc484a3c85afa62e0829db88fcf8): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 157

Backtrace:

File: /var/www/meetingsint/application/controllers/Conference.php
Line: 10
Function: __construct

File: /var/www/meetingsint/index.php
Line: 317
Function: require_once

Pharmaceutical chemistry conferences 2018 | Pharma Chemistry Meetings | Pharma Symposiums

2nd International Conference on

Pharmaceutical Chemistry

Paris | France   July 16-17, 2018

Theme: Exploring the Challenges in Pharmaceutical Chemistry & Process of Drug Discovery for the Future

Meetings International proudly invites all the participants from all over the world to attend “International Conference on Pharmaceutical Chemistry” during July 16-17, 2018 at Paris, France.  

Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. Meetings Int. supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings Int. is to communicate science and medical research between academia, and industry. Through inspiring sessions and tons of networking, you will learn to be even more audacious and bold than you are now and free to grow your mind, grow your business, and grow your bottom-line. We can relieve you of the time and resource draining elements of the events that you plan to hold. From planning to coordinating, start to finish; we will be there to ensure you take the accolades for yet another brilliant program. We organize conferences world-wide. All major conferences of Meetings International are accredited with Continuing Professional Development (CPD), Continuing Education (CE), and Continuing Medical Education (CME) Credits.

 

Why to Attend:

This is the platform where you can exchange your ideas and learn novel concepts related to your field from the international speakers as well as the professionals participating in this symposium. We want to take every individual related to this field either to learn or share your experience in this field and improve your connections from the entire globe.

It’s important to share knowledge with others due to newly generated problem. For that they need a platform to share their knowledge. We could say we create a golden opportunity for those people expose their knowledge through this Pharmachemistry Conference.

In addition to attending the conference, we invite you to experience Paris, the beautiful and famous city in France, which attracts people from around the world. Paris is known for its many monuments, especially the Eiffel Tower. It is no wonder that the city is one of the most popular tourist destinations in the world and welcomes over 45 million visitors every year.

 

Pharmaceutical Chemistry 2018 Highlights are listed below:

Advanced Organic Chemistry and Inorganic Chemistry

Biopharmaceutical and Biologic Drugs

Drug Delivery techniques

Drug Designing Methodologies

Drug Discovery and Development

Drug Formulation / Pharmaceutical formulation

Green Chemistry in Pharma Industry

Heterocyclic Chemistry

Nanomedicine and Nanotechnology

Overview on Pharmaceutical Industry

Pharmaceutical Analysis

Pharmaceutical Biotechnology and Tissue Engineering

Pharmaceutical Chemistry Novel Aspects

Prospectives of Medicinal Chemistry

Protein and Cellular Engineering and Statistical Mechanics

Research Studies in Pharmacology

Neuropharmacology & Psychopharmacology

 

Target Audience:

Researchers, Scientists & Biotechnology Experts

Pharmaceutical & Biotechnology Companies

Healthcare Departments

Clinicians & Paramedical Professionals

Directors, CEO’s of Organizations

Faculty (Professors, Associate Professors, Asst. Professors )

Pharma and Chemistry Colleges & Training Institutes

Pharma and Chemistry Students

PhD Scholars, Graduates and Post Graduates

Sessions 1: Advanced Organic Chemistry and Inorganic Chemistry

Organic and inorganic chemistry are subdisciplines within chemistry. In organic chemistry, scientific study is concentrated towards carbon compounds and other carbon-based compounds such as hydrocarbons and their derivatives. Inorganic chemistry is concerned in the scientific study of all the chemical compounds except the carbon group. So organic chemistry deals with carbon while inorganic chemistry deals with the rest of the chemical compounds except carbon. When we say scientific study of organic or inorganic chemistry, this includes the study of structure, composition,  preparation, properties, and study of reactions. Organic chemistry includes stereochemistry, photochemistry isomerization, hydrogenation, polymerization, and fermentation. Inorganic chemistry includes crystallography, electrochemistry, atomic structure, chemical bonding, ceramics and acid-base reactions.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium

 

Sessions  2: Biopharmaceutical and Biologic Drugs

Biopharmaceutics is the study of the chemical and physical properties of drugs, their components, and their activities in living organisms. Because of the way they are made, these agents are often called biotech drugs and include therapeutic peptides and proteins, antibodies, oligonucleotides and nucleic acid derivatives, and DNA preparations.

Biopharmaceuticals are part of a broader category of therapeutic agents called biologics, defined as any therapeutic agent manufactured in living systems such as microorganisms, or animal and plant cells. Biologics not only include biopharmaceuticals, but also blood and blood components, vaccines, and other biomolecules extracted directly from natural sources.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  3:  Clinical and Hospital Pharmacy

Clinical and hospital pharmacy deals with the application of drug treatments to patients in a hospital or clinical setting. The study of pharmacy involves the effective recommendation and administration of various medications for the safety and health of patients. Clinical or hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapies. Hospital pharmacy is the health care service, which comprises the art, practice, and profession of choosing, preparing, storing, compounding, and dispensing medicines and medical devices, advising healthcare professionals and patients on their safe, effective and efficient use. Hospital pharmacy is a specialised field of pharmacy which forms an integrated part of patient health care in a health facility. Hospital pharmacy is the profession that strives to continuously maintain and improve the medication management and pharmaceutical care of patients to the highest standards in a hospital setting. Hospital pharmacists provide services to patients and health care professionals in hospitals.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  4:  Computational Chemistry and Chemical Biology

Computational modelling has gained an increasingly important role in biochemical and biomolecular sciences over the past decades. This is related to significant developments in terms of methodology and software, as well as the amazing technological advances in computational hardware, and fruitful connections across different disciplines. Computational chemists develop and apply computer programs to answer key questions in biochemistry. They model, predict, visualize, and analyze the structures, functions, and interactions of biologically important molecules. In structure-based drug discovery and rational design, researchers seek to find and create small molecules (ligands) that selectively bind to proteins involved in disease processes to therapeutically alter their activity.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  5:  Drug Delivery techniques

Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. For the treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining increasing importance. These routes provide promising alternatives to parenteral drug delivery particularly for peptide and protein therapeutics. For this purpose, several drug delivery systems have been formulated and are being investigated for nasal and pulmonary delivery. These include liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins, among others. Nanoparticles composed of biodegradable polymers show assurance in fulfilling the stringent requirements placed on these delivery systems, such as ability to be transferred into an aerosol, stability against forces generated during aerosolization, biocompatibility, targeting of specific sites or cell populations in the lung, release of the drug in a predetermined manner, and degradation within an acceptable period of time.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  6: Drug Designing Methodologies

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Unique work on structure-based drug design, covering multiple aspects of drug discovery and development. Fully colored, many images, computer animations of 3D structures (these only in electronic form). Makes the spatial aspects of interacting molecules clear to the reader, covers multiple applications and methods in drug design. Structures by mode of action, no therapeutic areas. Of high relevance for academia and industrial research. Focus on gene technology in drug design, omics -technologies computational methods experimental techniques of structure determination multiple examples on mode of action of current drugs, ADME-tox properties in drug development, QSAR methods, combinatorial chemistry, biologicals, ribosome, targeting protein-protein interfaces.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  7: Drug Discovery and Development

Discovery

Researchers discover new drugs through: New insights into a disease process that allow researchers to design a product to stop or reverse the effects of the disease, Many tests of molecular compounds to find possible beneficial effects against any of a large number   of diseases, Existing treatments that have unanticipated effects, New technologies, such as those that provide new ways to target medical products to specific sites  within the  body or to manipulate genetic material. At this stage in the process, thousands of compounds may be potential candidates for development as a medical  treatment. 

Development

Once researchers identify a promising compound for development, they conduct experiments to gather information on: How it is absorbed, distributed, metabolized, and excreted. Its potential benefits and mechanisms of action. The best dosage, the best way to give the drug (such as by mouth or injection), side effects or adverse events that can often be referred to as toxicity. How it affects different groups of people (such as by gender, race, or ethnicity) differently. How it interacts with other drugs and treatments. Its effectiveness as compared with similar drugs.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  8: Drug Formulation / Pharmaceutical formulation

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  9: Green Chemistry in Pharma Industry

Green Chemistry, also called sustainable chemistry, is a philosophy of chemical research and engineering that encourages the design of product and processes that minimize the use and generation of hazardous substances. As a chemical philosophy, green chemistry applies to organic chemistry, inorganic chemistry, biochemistry, analytical chemistry, physical chemistry and even chemical engineering.

Green chemistry is a tool, which when implemented right, can help the industry achieve its environmental goals. Broadly defined as the design of chemical products and processes that reduce or eliminate the use and generation of hazardous substances, green chemistry allows companies to develop better products through sustainable processes.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  10: Heterocyclic Chemistry

Heterocyclic chemistry is the branch of organic chemistry dealing with the synthesis, properties, and applications of these heterocycles. Examples of heterocyclic compounds include all of the nucleic acids, the majority of drugs, most biomass (cellulose and related materials), and many natural and synthetic dyes. Heterocyclic compounds are of very much interest in our daily life. Heterocyclic compounds have one or more hetero atoms in their structure. They may be cyclic or non cyclic in nature. Heterocyclic compunds  have a wide range of application. They are predominantly used as pharmaceuticals, as agrochemicals and as veterinary products. They also find applications as sanitizers, developers, antioxidants, as corrosion inhibitors, as copolymers, dye stuff. They are used as vehicles in the synthesis of other organic compunds. Some of the natural products e.g. antibiotics such as penicillin’s, cephalosporin; alkaloids such as vinblastine, morphine, reserpine etc. have heterocyclic moiety.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  11: Nanomedicine and Nanotechnology

Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future. Nanotechnology is the engineering of functional systems at the molecular scale. It is the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  12: Natural Products Chemistry

Natural Products Chemistry & Research deals with chemical compounds found in nature that usually has a pharmacological or biological activity for use in pharmaceutical drug discovery and drug design. Natural Products Chemistry & Research emphasizes articles related to the study of chemistry and biochemistry of naturally occurring compounds or the biology of living systems from which they are obtained.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  13: Overview on Pharmaceutical Industry

The pharmaceutical industry is responsible for the development, production and marketing of medications. Understanding how Pharmaceutical & Biotech Companies Work, Role of Pharmaceutical in Healthcare, Drug Details, Drug Development Life Cycle, Drug Discovery.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  14: Pharmaceutical Analysis

Pharmaceutical Analysis is an Analytical Method used to determination the quality and quantity of the pharmaceutical products. It also gives the information about the purity and safety of the products. Briefly it can be described as it identifies, determines, quantifies, purifies and separates the active compound from the mixture.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  15: Pharmaceutical Biotechnology and Tissue Engineering

Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a scaffold for the formation of new viable tissue for a medical purpose. 

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  16: Pharmaceutical Chemistry Novel Aspects

Physicochemical and biological factors that contribute to drug action, Medicinal Radiocompounds or Radiopharmaceuticals, Global Pharmaceutical Policy, Impurities and Impurity Profile Significance in API, Design of Safer Chemicals and Products, In vivo and in vitro biotransformations of drugs.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  17: Prospectives of Medicinal Chemistry

Medicinal chemistry is a stimulating field as it links many scientific disciplines and allows for collaboration with other scientists in researching and developing new drugs. Medicinal chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the processes by which existing pharmaceuticals are made. Medicinal chemists are focused on drug discovery and development and are concerned with the isolation of medicinal agents found in plants, as well as the creation of new synthetic drug compounds.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions 18: Protein and Cellular Engineering and Statistical Mechanics

Protein engineers alter, design, and synthesize protein molecules for new and specialized uses, both to explore biology and to exploit new therapeutic opportunities. Their work includes monitoring vital biological processes via enzymes altered to affix affinity labels and proximity tags, or via recombinant antibodies that selectively bind other proteins, disclosing their locations, co-factors and activities. Such engineering could eventually lead to the molecular-level diagnosis of disease, as well as more precise treatment targeting and rapid analysis of therapeutic efficacy.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  19: Research Studies in Pharmacology

Clinical pharmacology - It is the science of drugs and their clinical use. It has a broad scope, from the discovery of new target molecules, to the effects of drug usage in whole populations. with added focus on the application of pharmacological principles and methods.

Pharmacotherapeutic trials - It is the scientific study or the trials that deals specifically with the treatment of disease and the science of healing including various drug therapies. It also refers to the use of drugs and the methods of their administration in the treatment of disease.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric Pharmacology, Switzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

Sessions  20: Neuropharmacology & Psychopharmacology

Neuropharmacology is a science concerned with drug-induced changes in the functioning of cells in the nervous system while psychopharmacology is the branch of pharmacology which related to the psychoactive aspects of drugs.

Related Conferences & Societies: Principles of Pharma Market Access in Europe, 05 Dec 2017, London, United Kingdom; Social Media in the Pharmaceutical Industry, 22 Jan 2018, London, United Kingdom; Drug Discovery 2018, 21 Mar 2018, London, United Kingdom; International Pharmaceutical Conference and Expo, 21 Mar 2018, Philadelphia, United States. European Association for Clinical Pharmacology and Therapeutics, France;  European Association for Veterinary Pharmacology and Toxicology,  France; European Behavioural Pharmacology Society, France;  European College of Neuropsychopharmacology, Netherlands; European Society of Biochemical Pharmacology, Germany; Perinatal and Paediatric PharmacologySwitzerland; European Society of Ethnopharmacology  (ESE), France; Federation of European Pharmacological Societies (EPHAR), London;  European Generic Medicines Association, Belgium 

 

Market Analysis

Importance & Scope

Pharmachemistry Conference is a best platform to present and discuss current aspect in drug research and development. Pharmachemistry is the study of interaction of chemical with living systems. It is important to discuss the pharmacological basis of therapeutics in order to maximize the benefits and minimize the risks of drugs to recipients. Hence it will be the best platform for scientists, researchers, PhD Scholars, Graduates and Post Graduates involved with drug development.

Global Business & Research Value

The global excipients market should reach nearly $6.9 billion by 2020 from approximately $6.3 billion in 2015, at a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020. The pharmaceutical business is in charge of the creation, improvement and advertising of drugs. In this manner, its huge significance as a worldwide segment is inarguable. In 2014, add up to pharmaceutical incomes worldwide had surpassed one trillion U.S. dollars out of the blue. North America is in charge of the biggest bit of these incomes, because of the main part of the U.S. pharmaceutical industry. In any case, as in numerous different ventures, the Chinese pharmaceutical division has demonstrated the most elevated development rates over earlier years.  In any case, the main pharmaceutical organizations originate from the United States and Europe. In view of solution deals, NYC-based Pfizer is the world's biggest pharmaceutical organization. In 2016, the organization produced nearly 52.8 billion U.S. dollars in unadulterated pharmaceutical deals. Other best worldwide players from the United States incorporate Johnson and Johnson, Merck and AbbVie.

Global Universities

Top universities for  Pharmacology and Pharmachemistry –

Braunschweig University of Technology, Germany

Goethe University Frankfurt, Germany

Joseph Fourier University, France

University of Bologna, Italy

Aston University, United Kingdom

University of Barcelona, Spain

Charles Sturt University, Australia

Fukuyama University, Japan

Adamson University, Philippines

Pusan National University, Singapore

Gulf Medical University, United Arab Emirates

University of Pittsburgh, USA

Texas Southern University, USA

Federal University of Bahia, Brazil

Laval University, Canada

National University of Colombia

Global Research Centres

3M Pharmaceuticals

Abbott Laboratories

AbbVie

Acadia Pharmaceuticals

Acorda Therapeutics

Actavis

Actelion

Adcock Ingram

Advanced Chemical Industries

Advaxis

ACG Worldwide

Global Funding Bodies

Aga Khan Foundation – AKF

Alexander von Humboldt Foundation

American Association of University Women-International Fellowships

Andrew W. Mellon Foundation

Boehringer Ingelheim Fonds

Centre for Disease Control (CDC)

Commonwealth Fund

Community of Science

Ford Foundation

Gates (Bill and Melinda) Foundation

Izumi Foundation

National Science Foundation

Major Associations in Europe

European Association for Clinical Pharmacology and Therapeutics

European Association for Veterinary Pharmacology and Toxicology

European Behavioural Pharmacology Society

European College of Neuropsychopharmacology

European Society of Biochemical Pharmacology

European Society of Developmental, Perinatal and Paediatric Pharmacology

European Society of  Ethnopharmacology  (ESE)

Federation of European Pharmacological Societies (EPHAR)

European Generic Medicines Association

Future Scope Pharmaceutical chemistry

Pharmaceutical chemistry  is widen & inter-related with the every steps of medical science such as Diagnosis prevention & treatment purpose.

Conclusion

Pharmaceutical chemistry and analytical chemistry together make eminent growth in the pharmacy or medical industry.

A knowledge of the concepts of drug metabolism is useful in both the design of new drugs and the improvement of existing drugs.

Thus it effects the living life in a affective way.

  • Advanced Organic Chemistry and Inorganic Chemistry
  • Biopharmaceutical and Biologic Drugs
  • Clinical and Hospital Pharmacy
  • Computational Chemistry and Chemical Biology
  • Drug Delivery Techniques
  • Drug Designing Methodologies
  • Drug Discovery and Development
  • Drug Formulation / Pharmaceutical Formulation
  • Green Chemistry in Pharma Industry
  • Heterocyclic Chemistry
  • Nanomedicine and Nanotechnology
  • Natural Products Chemistry
  • Neuropharmacology & Psychopharmacology
  • Overview on Pharmaceutical Industry
  • Pharmaceutical Analysis
  • Pharmaceutical Biotechnology and Tissue Engineering
  • Pharmaceutical Chemistry Novel Aspects
  • Prospectives of Medicinal Chemistry
  • Protein and Cellular Engineering and Statistical Mechanics
  • Research Studies in Pharmacology

17 Organizing Committee Members

17 Renowned Speakers

Ling PENG

Aix-Marseille University
France

Chang-Guo Zhan

University of Kentucky
USA

Janine Cossy

ESPCI Paris Tech
France

Alexander Sirotkin

University of Constantine the Philosopher
Slovakia

Chris Meier

University of Hamburg
Germany

Tomader Ali

University of Brighton
UK

Larisa Klapshina

Nizhny Novgorod State University
Russia

Oara Neumann

Rice Unicversity
USA

Christina Yuen Ki Leung

University of Hong Kong
Hong Kong

Olga I Lavrik

Novosibirsk State University
Russia

Alexandros G. Georgakilas

National Technical University of Athens
Greece

Bhaskar Chakraborty

University of Sikkim
India

Gurusamy Mariappan

Jawaharlal Nehru Technological University
India

Jorge I. Gonzalez Borroto

Pharmacovigilance Officer Ferrer Internacional
Spain

Morgane Renault-Mahieux

Paris Descartes University
France

Bahman Ebrahimi Saatloo

University of Urmia
Iran

Begum Nurpelin Saglik

Anadolu University
Turkey

Media Partners & Collaborations

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Collaboration

  • Collaboration

A PHP Error was encountered

Severity: Warning

Message: Unknown: Failed to write session data (user). Please verify that the current setting of session.save_path is correct (/var/www/meetingsint/application/ci_session)

Filename: Unknown

Line Number: 0

Backtrace: